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Background: Mesencephalic astrocyte-derived neurotrophic factor (MANF), a 20 kDa secreted protein, was
originally derived from a rat mesencephalic type-1 astrocyte cell line. MANF belongs to a novel evolutionally
conserved family of neurotrophic factors along with conserved dopamine neurotrophic factor. In recent years,
ever-increasing evidence has shown that both of them play a remarkable protective role against various injuries to
neurons in vivo or in vitro. However, the characteristics of MANF expression in the different types of glial cells,
especially in astrocytes, remain unclear.
Methods: The model of focal cerebral ischemia was induced by rat middle cerebral artery occlusion.
Double-labeled immunofluorescent staining was used to identify the types of neural cells expressing MANF.
Primarily cultured glial cells were used to detect the response of glial cells to endoplasmic reticulum stress
stimulation. Propidium iodide staining was used to determine dead cells. Reverse transcription PCR and western
blotting were used to detect the levels of mRNA and proteins.
Results: We found that MANF was predominantly expressed in neurons in both normal and ischemic cortex.
Despite its name, MANF was poorly expressed in glial cells, including astrocytes, in normal brain tissue. However,
the expression of MANF was upregulated in the glial cells under focal cerebral ischemia, including the astrocytes.
This expression was also induced by several endoplasmic reticulum stress inducers and nutrient deprivation in
cultured primary glial cells. The most interesting phenomenon observed in this study was the pattern of MANF
expression in the microglia. The expression of MANF was closely associated with the morphology and state of
microglia, accompanied by the upregulation of BIP/Grp78.
Conclusions: These results indicate that MANF expression was upregulated in the activated glial cells, which may
contribute to the mechanism of ischemia-induced neural injury.
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Mesencephalic astrocyte-derived neurotrophic factor
(MANF), a 20 kDa secreted protein, was initially isolated
and purified from culture medium of immortalized rat
type-1 astrocytes (also named ventral mesencephalic cell
line 1 (VMCL1)) [1]. The gene encoding MANF is
located in human chromosomal band 3p21 [2], and
highly conserved gene mutations were detected in early-
stage tumors [3]. The MANF gene was therefore also
named arginine-rich, mutated in early stage of tumors
(ARMET or ARP). However, the variations were found
to be normal polymorphisms rather than tumor-specific
mutations shortly after the report [4]. Subsequent studies
showed that MANF protein does not contain an arginine-
rich region and has neurotrophic effects with selectivity for
dopaminergic neurons [1,5]. MANF, together with con-
served dopamine neurotrophic factor (CDNF), belongs
to a novel and evolutionally conserved family of neuro-
trophic factors [5]. Human MANF shares 59% amino
acid identity with CDNF. The study on MANF solution
structure revealed that MANF is composed of two
domains, a saposin-like N-terminal domain and a well-
conserved flexible C-terminal domain with a cysteine
bridge [6,7]. The cysteine bridge may be involved in
catalyzing the formation of intramolecular disulfide
bonds and protein folding in the endoplasmic reticulum
(ER) because of its similarity to the active site motif of
thiol/disulfide oxidoreductases [8,9].
MANF is an ER stress inducible protein [5,10]. MANF
expression was upregulated by various ER stress inducers
in neural cell lines and in the cerebral ischemic tissue
in vivo [5,10]. Similarly, MANF mRNA increased after
brain ischemia and epileptic insults in the hippocampus
and in the cerebral cortex [11]. Increasing evidence
indicates that MANF plays a remarkable protective role
against various injuries to neurons in vivo or in vitro
[1,10,11]. Recombinant MANF promoted neuron prolif-
eration and prevented neuron apoptosis induced by
tunicamycin [12]. The upregulation of MANF after insults
could therefore possibly result from activation of endogen-
ous neuroprotective processes.
Glial cells, especially astrocytes, are the major component
of neural tissues. These cells are critical participants in
every major aspect of brain development, function, and
disease. MANF is so named because of its origin [1]. As
mentioned above, the induction and neuroprotection of
MANF in neurons have been well demonstrated. However,
the characteristics and the elaborate patterns of MANF
expression in glial cells, especially in the astrocytes, have
not been reported until now. In this study, the profiles of
MANF expression and induction in vivo and in vitro were
investigated in three types of glial cells, including astrocytes,
microglia, and oligodendrocytes. In addition, the accom-
panied ER stress-induced glial death was also examined.Materials and methods
Animals
Male Sprague–Dawley (SD) adults (grade SPF, weighing
200 to 240 g) and pregnant SD rats (grade SPF) were
obtained from Anhui Experimental Animal Center
(Hefei, China). The rats were kept under standard lighting
conditions (12-hour light/dark cycle). The procedure for
animal surgery was performed in accordance with the
Guidelines of Animal Care and Use Committee of Anhui
Medical University.
Materials
Specific mAb against MANF was prepared according to
the method described previously [13]. Mouse anti-rat
CD68 (catalogue number MCA341GA) was obtained
from Serotec (Indianapolis, IN, USA). Mouse anti-NeuN
(catalogue number MAB377) was obtained from Millipore
(Billerica, MA, USA). Rabbit polyclonal to binding protein
for immunoglobulins/glucose-regulated protein of 78
kDa (BIP/Grp78) antibody (catalogue number ab53068)
was obtained from Abcam Ltd (Hongkong, China). Alexa
Fluor-488 labeled anti-mouse IgG (catalogue number
A11029) and Alexa Fluor-568 labeled anti-rabbit IgG
(catalogue number A11036) were obtained from Invitrogen
Corporation (Carlsbad, CA, USA). The 3,30-diaminobenzi-
dine tetrahydrochloride substrate was purchased from Vec-
tor Laboratories (Burlingame, CA, USA). The BCA Protein
Assay Kit was from Thermo Fisher Scientific (Rockford, IL,
USA). Horseradish peroxidase-conjugated anti-mouse and
anti-rabbit IgG (catalogue number P0217) was from Dako
(Glostrup, Denmark). MG132 was from Tocris Bioscience
(Ellisville, MO, USA). All other antibodies and chemicals
were obtained from Sigma-Aldrich (St Louis, MO, USA).
Middle cerebral artery occlusion
The animal study was approved by the Animal Care and
Use Committee in Anhui Medical University. All SD rats
were treated according to the Guide for the Care and
Use of Laboratory Animals. Male SD rats were obtained
and bred as described previously [12]. The focal ischemia
models were set up by middle cerebral artery occlusion as
described previously [12]. Briefly, the rats were anesthe-
tized and the right common carotid artery was exposed
allowing the insertion of a nylon filament (0.235 mm in
diameter) to the end of the internal carotid artery to block
the origin of the right middle cerebral artery. Two hours
or 4 hours after the occlusion, the nylon filament was
withdrawn to allow reperfusion for 24 hours. The rats
were sacrificed under deep anesthesia.
Primary glial cell culture
Pregnant SD rats at embryonic days 16 to 18 were
deeply anesthetized and the embryos were taken out.
The cortexes and hippocampi were separated and placed
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Cells were mechanically dissociated in a nutrient
medium by triturating with a flame-polished sterile
Pasteur pipette. Cell debris was removed by centrifugation.
The cells were resuspended in DMEM containing 10%
fetal bovine serum and 10% horse serum and plated onto
24-well plates precoated with poly-D-lysine. The cells
were incubated in a humidified incubator at 37°C with 5%
CO2 and the medium was changed every 2 or 3 days. After
several days of culture, the cells were exposed to low
serum (5%), MG132 (10 μmol/l), tunicamycin (1 μg/ml)
for 24 hours. The cells were then collected for western
blotting or fixed in phosphate-buffered 4% paraformalde-
hyde for immunofluorescent staining.
Immunofluorescent staining
Adult SD rats were deeply anaesthetized with 10% chloral
hydrate (3 ml/kg, intraperitoneally) and transcardially
perfused with 4% paraformaldehyde in PBS (pH 7.4).
Brains were then removed and subsequently placed in the
same paraformaldehyde solution until further processing.
The tissue was dehydrated through ethanol and xylene,
and then embedded in paraffin. Four-micrometer coronal
sections were processed for immunofluorescent staining
using standard procedures. Briefly, brain sections were
hydrated and rinsed in PBS. After antigen retrieval,
sections were permeabilized/blocked in PBS containing
0.5% Triton X-100 and 5% goat serum. The sections were
incubated with primary antibody overnight at 4°C. Negative
controls were performed by substituting the primary
antibody with PBS. MANF antibodies were prepared as
described previously [12]. For dual fluorescent staining, the
sections were incubated with Alexa Fluor 488-conjugated
or 568-conjugated IgG (Invitrogen, Carlsbad, CA, USA)
and observed under fluorescent microscopy (Olympus,
Tokyo, Japan). Immunocytofluorescent staining was per-
formed as described previously [12]. 40,6-diamidino-2-phe-
nylindole was used to stain the nuclei. The images were
taken under a fluorescent microscope.
Western blotting
Cultured cells were harvested and lysed with 10 volumes
of 1×SDS sample buffer. The samples were boiled for 5
minutes and processed for SDS-PAGE and subsequent
western blotting. Briefly, after blocking with 5% nonfat
milk in PBS for 30 minutes, the membranes were incubated
with primary and secondary antibodies for 1 hour at room
temperature, respectively. The immunoreactive signals were
visualized using the enhanced chemiluminescence kit from
Pierce (Rockford, IL, USA). For the relatively quantitative
analysis of western blot, the densitometry was carried out
in Photoshop software (Adobe, San Jose, CA, USA). The
levels of the proteins were normalized to the level of
glyceraldehyde-3-phosphate dehydrogenase.Reverse transcription PCR
Total RNA was isolated with TRIZOL reagent (Invitrogen)
according to the manufacturer’s instructions. Reverse
transcription was performed with AMV from Promega
(Madison, WI, USA) using the manufacturer’s protocol.
Amplification primers were as follows: 50-GGA GCT GGA
AGC CTG GTA TGA-30 (forward) and 50-TCC CTG GTC
AGG CGC TCG ATT T-30 (reverse) for CCAAT/-enhan-
cer-binding protein homologous protein (CHOP); 50-GGT
ATT GAA ACT GTG GGA GG-30 (forward) and 50-TTG
TCT TCA GCT GTC ACT CG-30 (reverse) for BIP;
50-TCC GCT ACT GTA AGC AAG GT-30 (forward) and
50-CTT CAC CTA GGA TCT TGG TG-30 (reverse) for
MANF; and 50-TCA AGA TCA TTG CTC CTC CTG
AG-30 (forward) and 50-ACA TCT GCT GGA AGG TGG
ACA-30 (reverse) for β-actin.
Propidium iodide staining
Propidium iodide staining was used to identify dead
cells. Glial cells were grown on poly-D-lysine-coated
coverslips and treated with ER stress inducers. The cells
were then fixed in 70% ethanol for at least 30 minutes at
4°C. To ensure that only DNA was stained, cells were
treated with 50 μl RNase (100 μg/ml). The cells were
then stained with 200 μl propidium iodide (50 μg/ml).
The images were taken under fluorescent microscopy.
Statistical analysis
Data are expressed as the mean ± standard error of the
mean. Multiple comparisons were statistically evaluated
by a one-way analysis of variance between-groups test. A
significance level of 5% was used in all statistical tests.
Results
Ischemia-induced MANF expression in the astrocytes
MANF was so named because it was originally isolated
from a rat mesencephalic astrocyte line [1] . However,
the pattern of MANF expression in astrocytes has not
been reported. We first examined the expression of
MANF in astrocytes by double-labeled immunofluorescent
staining. Negative controls were performed to show the
specificity of anti-MANF antibody in the brain tissue by
substituting the primary antibody with PBS (Figure 1M,N,
O,P). Glial fibrillary acidic protein and NeuN (a neuronal-
specific nuclear protein) were used as the markers for
astrocytes and neurons, respectively. To our surprise, unlike
its name, MANF was predominately expressed in the
NeuN-positive neurons (Figure 1J,K,L), but not in astro-
cytes (Figure 1A,B,C), in the normal rat cortex. Slight
ischemia (focal ischemia for 2 hours) upregulated MANF
expression in the glial fibrillary acidic protein-negative
neural cells (Figure 1D,E,F). However, severe ischemia
(focal ischemia for 4 hours with remarkable tissue edema)
induced MANF expression in the astrocytes (Figure 1G,H,
Figure 1 (See legend on next page.)
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Figure 1 Mesencephalic astrocyte-derived neurotrophic factor expression in the astrocytes of brain tissue. Brain samples were collected
from the normal (A to C) and ischemic rat brain tissue (D to L). (D to F) and (J to L) Two-hour ischemia followed by 24-hour reperfusion; (G to I)
4-hour ischemia followed by 24-hour reperfusion. (A to I) Mesencephalic astrocyte-derived neurotrophic factor (MANF) expression in astrocytes was
detected by double immunofluorescent staining for glial fibrillary acidic protein (GFAP) (red, A, D, and G) and MANF (green, B, E, and H) with anti-
GFAP and anti-MANF, respectively. (J to L) MANF expression in neurons was detected with anti-MANF (red, K). The neurons were identified by anti-
NeuN (green, J). Ischemia-induced MANF expression was found predominantly in neurons (K). A small number of astrocytes expressing MANF are
indicated by arrows. Scale bar = 50 μm. (M to P) Specificity of the antibody against MANF in brain tissues was detected by immunohistochemistry
and immunofluorescent staining. Brain sections were incubated with primary antibody (anti-MANF) in (N) and (P). Negative controls were
performed by substituting the primary antibody with PBS (M and O). Scale bar = 50 μm.
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cells in the astrocytes is shown in Figure 2S, and was less
than that in microglia and oligodendrocytes.
Further study was carried out in cultured primary
astrocytes. Consistently, MANF was almost undetectable
in astrocytes cultured in medium containing 5% fetal
bovine serum (Figure 3A,B,C), but it was induced in cells
treated with ER stress inducers, including tunicamycin
(an inhibitor of protein glycosylation) (Figure 3D,E,F,
indicated by arrows), proteasome inhibitor MG132
(Figure 3G,H,I, indicated by arrows), and nutrition star-
vation with serum-free culture medium (Figure 3J,K,L,
indicated by arrows). The upregulation was further sup-
ported by the increases in MANF mRNA and protein as
revealed by RT-PCR and western blotting, respectively
(Figure 4A,B,C,D). These results suggest that expression
MANF is inducible under stress condition in astrocytes
but is constitutively expressed in neurons.
Ischemia-induced microglial activation and MANF
expression
Activation of microglia has been found in acute and
chronic neuroinflammation and neurodegenerative
diseases. To learn more about MANF expression in glial
cells, we also detected MANF in microglia using
immunofluorescent double staining with anti-MANF
and anti-CD68, a marker of microglia. There were few
CD68-positive microglia cells in the cortex, except for
those that appeared in the small vessels (Figure 5A to H,
indicated by arrows), and these cells did not express
detectable levels of MANF. However, many CD68-
positive microglia were found in the ischemic cortex
with detectable MANF (Figure 5I to T). Additionally,
the expression of MANF in microglia depended on the
morphologies of microglia. For example, MANF-positive
microglial cells were slightly rod-shaped or ramified
(Figure 5I,J,K,L, indicated by arrows). However, the
amoeboid-like or round microglial cells displayed a
strong MANF immunostaining (Figure 5M to T). The
induction of BIP/Grp78 was also observed in both the
rod-shaped and round microglial cells in the ipsilateral
ischemic cortex, but not in the contralateral nonischemic
cortex (Figure 6A to H), suggesting ER stress is involved
in ischemia-induced microglial activation.Similar patterns of MANF expression were observed
in cultured primary microglia, but not in the ramified
microglial cells (Figure 7A,B,C,D). After exposure to
tunicamycin for 24 hours, the shapes of microglia were
changed to amoeboid (Figure 7E) or round (Figure 7I),
and MANF expression was upregulated (Figure 7F,J).
These results support the findings described in vivo.Ischemia-induced MANF expression in oligodendrocytes
The expression of MANF was also determined in oligo-
dendrocytes in the present study. The myelin protein
2030-cyclic nucleotide 30-phosphodiesterase (CNP) was
used as a marker of oligodendrocytes. In the normal
cortex, a large amount of branched processes and a
small amount of cell bodies were detected, and the
CNP-positive fibers were thicker and arranged in an
ordered radial pattern (Figure 2B, arrows show the
soma). MANF, however, was expressed in the soma
(Figure 2D, indicated by arrows), and the amount of
branched processes was reduced in the ischemic cortex
(Figure 2E). When double-labeled with 40,6-diamidino-2-
phenylindole, a small amount of MANF was found in the
nuclei (Figure 2G,H,I,J). As in the astrocytes and microglia,
MANF expression was upregulated in oligodendrocytes
after treatment with tunicamycin (Figure 2O,P,Q,R). These
results indicate that MANF was induced in oligoden-
drocytes not only by focal cerebral ischemia but also
by ER stress.Induction of ER stress and MANF expression in a mixed
culture of the primary glial cells
Our previous study demonstrated that MANF is an ER
stress inducible protein [8]. Here we have shown that
MANF was induced in the glial cells that were exposed
to a variety of stimuli. BIP and CHOP were used as the
markers of ER stress. As we predicted, the levels of BIP
and CHOP were significantly upregulated both in
mRNA transcription (Figure 4A,B) and in protein trans-
lation (Figure 4C,D) after the cells were treated with
tunicamycin and MG132. However, nutrient starvation
(serum removal) exerted a lesser effect on the protein
level of CHOP. Similarly, the expression of MANF
mRNA and protein was increased in response to the
Figure 2 (See legend on next page.)
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Figure 3 Induction of mesencephalic astrocyte-derived neurotrophic factor expression in the primarily cultured astrocytes. Cells
cultured in the DMEM medium containing 5% serum were used as controls (A to C). Glial cells were cultured as described in Materials and
methods and treated with 1 μg/ml tunicamycin (D to F), 10 μM MG132 (G to I), and serum-free DMEM medium (J to L), respectively. Twenty-four
hours after treatment, the astrocytes were identified with anti-glial fibrillary acidic protein (anti-GFAP) antibody (red, A, D, G, and J). Mesencephalic
astrocyte-derived neurotrophic factor (MANF) expression was detected with monoclonal anti-MANF antibody (green, B, E, H, and K). Nuclei were
stained with 40,6-diamidino-2-phenylindole (blue). The arrows show MANF immune-positive astrocytes after treatment. Scale bar = 50 μm.
(See figure on previous page.)
Figure 2 Expression of mesencephalic astrocyte-derived neurotrophic factor in oligodendrocytes. Mesencephalic astrocyte-derived
neurotrophic factor (MANF) was expressed in normal cerebral cortex (A to C) and ischemic cerebral cortex (D to J). The primary cultured
oligodendrocytes were treated with vehicle (DMEM medium containing 5% serum) (K to N) or tunicamycin (1 μg/ml) (O to R). Twenty-four
hours after treatment, immunofluorescent staining was performed. The oligodendrocytes were identified with anti-2-3-cyclic nucleotide 3-
phosphodiesterase (anti-CNP) (red, B, E, I, M, and Q). MANF was detected with anti-MANF antibody (green, A, D, H, L, and P). Scale bar = 50 μm.
(S) Percentage of MANF-positive cells in neural cells. The number of MANF-positive cells and the number of double positive cells co-expressing
glial fibrillary acidic protein (GFAP), CD68, CNP, or NeuN were counted in five randomly selected fields under a high-power field (×400
magnification). The percentage of MANF expressing cells in the population of astrocytes, microglial, and oligodendrocytes was calculated.
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Figure 5 Differential expression of mesencephalic astrocyte-derived neurotrophic factor in the microglia in brain tissue. (A to D) A rod-
shaped microglial cell within blood vessel in the normal cerebral cortex. (E to H) A ramified microglial cell under vascular endothelium in the
normal cerebral cortex. (I to L) A rod-shaped microglial cell with weak mesencephalic astrocyte-derived neurotrophic factor (MANF)-positive
immunoreaction in the ischemic cerebral cortex. (M to P) An amoeboid microglial cell with MANF-positive immunoreaction in the ischemic
cerebral cortex. (Q to T) A round microglial cell with strong MANF-positive immunoreaction in the ischemic cerebral cortex. Microglial cells were
identified with anti-CD68 antibody (green, A, E, I, M, and Q). MANF was detected with monoclonal anti-MANF (red, B, F, J, N, and R). Nuclei were
stained by 40,6-diamidino-2-phenylindole (blue, C, G, K, O, and S). Scale bar = 50 μm.
(See figure on previous page.)
Figure 4 Endoplasmic reticulum stress and mesencephalic astrocyte-derived neurotrophic factor expression in cultured primary glial
cells. (A to D) Glial cells in the mixed culture were treated as indicated (serum+ control, DMEM medium containing 5% serum; Tm, tunicamycin,
1 μg/ml; MG132, 10 μM; serum–, serum-free DMEM medium). Twenty-four hours after treatment, the cells were collected and processed for RT-
PCR and immunoblotting (IB). Levels of mRNAs (A) and proteins (C) were quantitated and normalized by actin. The quantitative data in (A) and
(C) are shown in (B) and (D), respectively. Values expressed as mean ± standard error of the mean of three independent experiments. *P <0.05,
**P <0.01, and ***P <0.001, compared with serum+ control. (E to P) Glial cells were treated with serum+ (E to G), Tm (H to J), MG132 (K to M),
and serum– (N to P). Twenty-four hours after treatment, the cells were stained with 40,6-diamidino-2-phenylindole (F, I, L, and O) and propidium
iodide (G, J, M, and P), and then observed with a microscope under bright field (E, H, K, and N) and fluorescence. Scale bar = 50 μm.
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Figure 6 BIP induction in the microglia in the ischemic cerebral cortex. (A to D) Ramified microglial cells in the ischemic cerebral cortex.
(E to H) Round microglial cells in the ischemic cerebral cortex. Microglial cells were identified with anti-CD68 antibody (green, A and E). BIP
was detected with rabbit anti-BIP (red, B and F). Nuclei were stained by 40,6-diamidino-2-phenylindole (blue, C and G). Scale bar = 50 μm.
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stress upregulates MANF in glial cells.
CHOP, also known as growth arrest-inducible and
DNA damage-inducible gene 153 (GADD153), is the
proapoptotic protein that mediates ER stress-induced
apoptosis [14]. CHOP has been reported to play a pivotal
role in astrocyte death induced by oxygen and glucose
deprivation [15]. We were wondering whether the ER
stress inducers could cause glial cell death. To test this, the
dead cells were detected by propidium iodide staining and
40,6-diamidino-2-phenylindole staining. The morphology
of the glial cell was also observed under microscope. The
number of dead cells increased after treatment with tunica-
mycin (Figure 4J) or MG132 (Figure 4M), or under serum-
free culture condition (Figure 4P), suggesting that ER stress
induces glial cell death.
Discussion
We report in this article the expression patterns of
MANF in glial cells in vivo and in vitro. For the first
time the characteristics of MANF expression in the
different types of glial cells were revealed, and they were
not as expected given the history of MANF. Unlike its
name ’mesencephalic astrocyte-derived neurotrophic
factor’ suggests, the astrocytes were not the major source
of MANF in the brain tissue. Although there was a small
amount of MANF expression in normal tissue, the
MANF-positive cells were neurons, not astrocytes.
However, severe cerebral ischemia could induce MANFexpression in glial cells, including astrocytes and oligo-
dendrocytes. MANF was significantly upregulated in
neurons even by slight cerebral ischemia [12], suggesting
that the neurons are a major source of MANF in the
brain tissue. Nevertheless, MANF expression was easily
induced by ER stress inducers and nutrition deprivation
in the cultured primary glial cells, including astrocytes,
microglia, and oligodendrocytes, suggesting that the
expression of MANF in glial cells is stress inducible.
Collectively, these results indicate that MANF can be
induced and differentially expressed in glial cells, and that
neurons are the major source of MANF in the brain tissue.
Glial cells are the major population of cells in the
brain. All these glial cells synergistically supply nutrition,
maintain homeostasis, and participate in signal transmis-
sion in the central nervous system (CNS). Astrocytes,
the major glial cell type in the CNS, are associated with
both neuroprotection and cytotoxicity when they are
activated in response to toxic substances or disease
states. Astrocyte activation is one of the key components
of cellular responses to brain injuries and neurodegen-
eration [16]. We found that severe cerebral ischemia in
rats and ER stress inducers in vitro induced MANF
expression in astrocytes. The pattern of MANF expression
in astrocytes was different from that in other glial cells and
neurons, although it is still unclear why. This difference in
expression might be associated with the function of
astrocytes. Additionally, we also observed glial cell death
induced by ER stress in vitro. Nevertheless, further
Figure 7 Mesencephalic astrocyte-derived neurotrophic factor expression in cultured primary microglia. Glial cells were cultured as
described in Materials and methods. The serum concentration in DMEM was lowered from 10% to 5% during treatment. Immunofluorescent
staining was performed in vehicle controls (A to D) and 24 hours after treatment with 1 μg/ml tunicamycin (E to L). Microglia were identified
with anti-CD68 antibody (green, A, E, and I). Mesencephalic astrocyte-derived neurotrophic factor (MANF) expression was detected with
monoclonal anti-MANF antibody (red, B, F, and J). Nuclei were stained by 40,6-diamidino-2-phenylindole (blue, C, G, and K). Scale bar = 50 μm.
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expression of MANF in the astrocytes is neuroprotective
or neurodegenerative.
Microglia, the resident macrophages of the brain,
are usually kept in a quiescent ramified state under
physiological conditions. The microglia are extremely
plastic, and undergo a variety of morphological changes
according to their location and current role. A variety of
stimuli, including substances released by damaged neurons,
invading pathogens, phagocytosing debris, and released
proinflammatory mediators, can induce the morphological
changes of microglia. Each form of microglia is thought to
play a distinct functional role [17,18]. In this study, we
found that ischemia-induced MANF expression in micro-
glia depends on the state of microglia. MANF was only
expressed in the activated microglia in the tissue, such as
the amoeboid-shaped or round-shaped microglia. However,
ischemia-induced microglial aggregation in the cerebralcortex and hippocampal dentate gyrus did not upregulate
MANF expression (data not shown) despite the fact that
microglial aggregation in the hippocampal dentate gyrus is
a marker of mild hypoxic-ischemic brain insult [19]. The
relationship between MANF induction and microglia acti-
vation is not yet clear. Furthermore, the induction of BIP/
Grp78 was observed in both rod-shaped and round micro-
glial cells in the ipsilateral ischemic cortex, but not in the
contralateral nonischemic cortex, suggesting ER stress is
involved in ischemia-induced microglial activation.
The cascade of microglial activation is a fine-tuned
process that is also regulated by factors derived from
neurons and other glial populations, particularly astrocytes.
For example, astrocytes can induce the transformation of
amoeboid microglia into ramified microglial cells and
reduce proliferative activity [20]. The presence of activated
microglia is linked to increased neuronal damage. In con-
trast, ablation of microglia is also associated with increased
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part in the etiology of neuronal injury. CD68 (also called
ED-1) and Iba-1 were usually used to identify the microglial
cells. Iba-1 can recognize resting as well as activated micro-
glia. CD68 was also used as a marker of microglia [22-25].
High levels of CD68 expression are associated with
activated microglia, whilst low levels of expression are
associated with quiescent ramified microglia [22-24,26].
CD68-positive cells were present in all four types of
morphology [27], which was consistent with our findings
described in this study.
Oligodendrocytes are essential for the proper develop-
ment and function of axonal networks in the CNS. During
development, these myelin-forming cells are metabolically
the most active cells in the CNS [28]. The main proteins of
myelin, such as myelin basic protein and CNP, interact
with microtubules and microfilaments in oligodendrocytes
[29]. Our study found that ischemia and ER stress induced
MANF expression in the oligodendrocytes, accompanied
by a decrease in processes. However, the exact role of
MANF needs further investigation. Popko’s group reported
that severe ER stress induced by IFNγ in myelinating
oligodendrocytes during development caused oligo-
dendrocyte apoptosis [30]. Nevertheless, modest ER
stress induced by IFNγ in mature oligodendrocytes of
adult mice protected against experimental autoimmune
encephalomyelitis-induced demyelination, axonal damage,
and oligodendrocyte loss [31].
In recent years, several neurotrophic factors such as
brain-derived neurotrophic factor and glial cell line-
derived neurotrophic factor have been found and known
to regulate synaptic plasticity in the CNS [32,33]. MANF
is a novel neurotrophic factor and forms a novel evolu-
tionally conserved protein family along with CDNF [7].
Intracortical delivery of recombinant MANF protein [34]
or encoding MANF adeno-associated virus [35] protected
tissue from ischemic brain injury in vivo. Our previous
study had shown that recombinant human MANF was
protective to neurons [12]. These results suggest that
induction of MANF is probably protective to neural cells.
Recently, the crystal structure of MANF has revealed a
well-defined N-terminal domain belonging to the saposin
family and a mostly disordered C-terminal domain, which
support the bi-functional role of MANF. The C-terminal
domain of MANF is homologous to the SAP domain of
Ku70, a well-known inhibitor of pro-apoptotic Bcl-2-
associated X protein (Bax) [9]. Cellular studies have demon-
strated that MANF protected neurons intracellularly as
efficiently as Ku70 [9].
In this study we also found that both ER stress inducer
and nutrition deprivation upregulated BIP and CHOP
and caused glial death, which was similar to the findings
described by Oyadomari’s and Benavides’ groups [14,15].
CHOP is the first protein identified that mediates ERstress-induced apoptosis and much is known on the
roles of this molecule in apoptosis. CHOP could also
be induced by nutrient depletion such as glucose
deprivation and amino acid starvation [14]. CHOP favors
a pro-apoptotic drive at the mitochondria by proteins that
cause mitochondrial damage, cytochrome C release, and
caspase-3 activation. The target genes for CHOP include
growth and DNA damage protein 34 and ER oxidoreduc-
tin 1, which promote recovery from ER stress-mediated
translational repression in the ER.
Conclusions
This study demonstrated the patterns and characteristics
of MANF expression in different types of glial cells. The
results suggest that upregulated MANF expression is
associated with activated glial cells, which will help us to
understand the function of MANF and the mechanisms
of ischemia-induced neural injury.
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